References
- Rosebush P, Stewart T: A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:717–725
- Swett CC: Adverse reactions to chlorpromazine in medical patients: A report from the Boston Collaborative Drug Sur-veillance Program. Curr Ther Res 1975; 18:199–206
- McFarland RB: Fatal drug reaction associated with pro-chlorperazine (compazine). Report of a case characterized by jaundice, thrombocytopenia, and agranulocytosis. Am J Clin Pathol 1963; 50:284.
- Storrie MC, Scher M, McGuire J, Bokan J: Thrombocytopenia with absence of leukopenia associated with the use of neuro-leptics. J Clin Psychiatry 1978; 72:779–782
- Holt RJ: Neuroleptic drug-induced changes in platelet levels: J Clin Psychopharm 1984; 4:130–132
- Balon R, Berchou R: Hematologic side effects of psychotropicdrugs. Psychosomatics 1986; 217:119–127
- Ray JG: Neuroleptic malignant syndrome associated with thrombocytopenia. J Intern Med 1997; 241:245–247
- Delay J, Deniker P: Drug induced extrapyramidal syndromes. In: Vinken RJ, Bruyn GW, eds. Handbook of Clinical Neurol-ogy: Disease of the Basal Ganglia, Vol. 6, New York, Elsevier North-Holland 1968; 248–266
- Lenler-Peterson P, Hausen BD, Hasselstorm L: A rapidly progressing lethal case of neuroleptic malignant syndrome. Intensive Care Med 1990; 16:267–268
- Yao JK, Yassai P, Van Kammen DP: Increased turnover of platelet phosphotidyl inositol in schizophrenia, Prostaglandins Leukotrienes Essential Fatty Acids 1992; 46:38–46
- Kaiya H: Second messenger imbalance hypothesis of schizo-phrenia. Prostaglandins Leukotrienes Essential Fatty Acids 1992; 46:33–38
- Pletscher A: Liberation of catecholamines from blood plate-lets. Br I Pharmacol 1981 (February)
- Essali MA, Das I: Regulation of the platelet phosphoinositide system by antipsychotic drugs: A specific neuroleptic action. Schizophrenia Res 1990; 3:36–37
- Kaiya H, et al.: Accumulation of diacylglycerol in platelet phosphotidylinositide turnover in schizophrenia: A biological marker of good prognosis? Biol Psychiatry 1989; 26:669–676
- Loiseau P: Sodium valproate, platelet dysfunction, and bleed-ing. Epilepsia 1981; 22:141–146
- Tohen M, et al.: Blood dyscrasia with carbamazepine and valproate: A pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry 1995; 152: 413–418
- Vadney V: Unusual clusters of valproate-associated thrombo-cytopenia. J Epilepsy 1992; 5:186–190